Everyday Health (EVDY) Misses Q3 EPS by 1c; Announces Launch of TVRx
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Everyday Health (EVDY) Says Sales Execution Problems Affected Consumer Segment; Leerink Partners Reiterates Outperform
November 11, 2015 6:51 AM ESTLeerink Partners maintained an Outperform rating on Everyday Health (NYSE: EVDY), and cut the price target to $15.00 (from $27.00), following the company's 3Q earnings report. Everyday Health reported 3Q15 revenue of $54.3m, $2.5m or 4% below Street expectations. Management lowered guidance for 2015 by 5% from $240m... More
